SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001012975-18-000083
Filing Date
2018-01-19
Accepted
2018-01-19 16:56:04
Documents
1
Period of Report
2018-01-17

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 23169
  Complete submission text file 0001012975-18-000083.txt   24883
Mailing Address 19 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 19 FIRSTFIELD ROAD GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Issuer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 19 FIRSTFIELD ROAD SUITE 200 GAITHERSBURG MD 20878
Business Address 5 RUE DE LA BAUME PARIS I0 75008 (240) 654-1450
Truffle Capital S.A.S. (Reporting) CIK: 0001706034 (see all company filings)

State of Incorp.: I0 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-32587 | Film No.: 18537933